Literature DB >> 18947298

Biomarkers for prostate cancer.

Danil V Makarov1, Stacy Loeb, Robert H Getzenberg, Alan W Partin.   

Abstract

The development of biomarkers for prostate cancer screening, detection, and prognostication has revolutionized the management of this disease. Prostate-specific antigen (PSA) is a useful, though not specific, biomarker for detecting prostate cancer. We review the literature on prostate cancer biomarkers, including serum markers (PAP, tPSA, fPSA, proPSA, PSAD, PSAV, PSADT, EPCA, and EPCA-2), tissue markers (AMACR, methylated GSTP1, and the TMPRSS2-ETS gene rearrangement), and a urine marker (DD3PCA3/UPM-3). Future research should focus on validation of already existing biomarkers and the discovery of new markers to identify men with aggressive prostate cancer.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 18947298     DOI： 10.1146/annurev.med.60.042307.110714

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  48 in total

1.  A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy.

Authors:  Antonino Sottile; Cinzia Ortega; Alfredo Berruti; Monica Mangioni; Sara Saponaro; Alessandra Polo; Veronica Prati; Giovanni Muto; Massimo Aglietta; Filippo Montemurro
Journal:  Oncol Lett       Date:  2012-01-16       Impact factor: 2.967

2.  Highlights from the prostate cancer genome report.

Authors:  Shyh-Han Tan; Gyorgy Petrovics; Shiv Srivastava
Journal:  Asian J Androl       Date:  2011-06-13       Impact factor: 3.285

3.  A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.

Authors:  Lori J Sokoll; Martin G Sanda; Ziding Feng; Jacob Kagan; Isaac A Mizrahi; Dennis L Broyles; Alan W Partin; Sudhir Srivastava; Ian M Thompson; John T Wei; Zhen Zhang; Daniel W Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

Review 4.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

5.  Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.

Authors:  Michal Harel; Pazit Oren-Giladi; Orit Kaidar-Person; Yuval Shaked; Tamar Geiger
Journal:  Mol Cell Proteomics       Date:  2015-01-26       Impact factor: 5.911

6.  Highly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers.

Authors:  LiNa Loo; Joseph A Capobianco; Wei Wu; Xiaotong Gao; Wan Y Shih; Wei-Heng Shih; Kambiz Pourrezaei; Matthew K Robinson; Gregory P Adams
Journal:  Anal Chem       Date:  2011-03-30       Impact factor: 6.986

7.  Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.

Authors:  K Mwamukonda; Y Chen; L Ravindranath; B Furusato; Y Hu; J Sterbis; D Osborn; I Rosner; I A Sesterhenn; D G McLeod; S Srivastava; G Petrovics
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-07-14       Impact factor: 5.554

8.  Novel diagnostic biomarkers for prostate cancer.

Authors:  Chikezie O Madu; Yi Lu
Journal:  J Cancer       Date:  2010-10-06       Impact factor: 4.207

9.  Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.

Authors:  Lara H El Touny; Partha P Banerjee
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 10.  PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer.

Authors:  Sema Nur Ayyıldız; Ali Ayyıldız
Journal:  Turk J Urol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.